AGC Biologics expands plasmid manufacturing capacity

By The Science Advisory Board staff writers

June 30, 2020 -- AGC Biologics is expanding its plasmid DNA (pDNA) Center of Excellence in Heidelberg, Germany, to meet the need for process development and manufacturing of pDNA.

The contract development and manufacturing organization is investing $1.1 million to build a laboratory that significantly expands lab area and provides additional staffing and equipment. The company will work to develop high-throughput techniques and quality-by-design processes to expand its service portfolio in plasmid manufacturing, which was established more than seven years ago.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.